Association of the tumour necrosis factor-α polymorphisms rs361525 and rs1800629 with susceptibility to psoriasis: A meta-analysis

Clinical and Experimental Dermatology

Volumn 38, Issue 8, 2013, Pages 836-844

  Jia, Y ^a   Qin, H J ^a   Zhang, J X ^a   Liu, X L ^a   Li, L J ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HLA SYSTEM; HUMAN; META ANALYSIS; ONSET AGE; PRIORITY JOURNAL; PSORIASIS;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888111028     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12136     Document Type: Article

References (25)

1. Elder JT, Bruce AT, Gudjonsson JE, et al,. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 2010; 130: 1213-1226.
2. Elahi MM, Asotra K, Matata BM, Mastana SS,. Tumor necrosis factor alpha -308 gene locus promoter polymorphism. An analysis of association with health and disease. Biochim Biophys Acta 2009; 1792: 163-172.
3. Reich K, Huffmeier U, Konig IR, et al,. TNF polymorphisms in psoriasis. Association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele. Arthritis Rheum 2007; 56: 2056-2064.
4. Li C, Wang G, Gao Y, et al,. TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis. J Invest Dermatol 2007; 127: 1886-1892.
5. Reich K, Mossner R, Konig IR, et al,. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol 2002; 118: 155-163.
6. Hohler T, Kruger A, Schneider PM, et al,. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997; 109: 562-565.
7. Tsunemi Y, Nishibu A, Saeki H, et al,. Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients. Dermatology 2003; 207: 371-374.
8. Long F, Sun C, Deng D, et al,. TNF-238A is associated with juvenile onset psoriasis in patients of Han population in southwest China. J Dermatol Sci 2004; 36: 109-111.
9. Mossner R, Kingo K, Kleensang A, et al,. Association of TNF -238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol 2005; 124: 282-284.
10. Rahman P, Siannis F, Butt C, et al,. TNF-alpha polymorphisms and risk of psoriatic arthritis. Ann Rheum Dis 2006; 65: 919-923.
11. Gallo E, Cabaleiro T, Román M, et al,. Study of genetic polymorphisms in the tumor necrosis factor α promoter region in Spanish patients with psoriasis. Actas Dermosifiliogr 2012; 103: 301-307.
12. Reich K, Westphal G, Schulz T, et al,. Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 1999; 113: 214-220.
13. Hamamoto Y, Tateno H, Ishida T, Muto M,. Lack of association between promoter polymorphism of the tumor necrosis factor-alpha gene and psoriatic arthritis in Japanese patients. J Invest Dermatol 2000; 115: 1162-1164.
14. Craven NM, Jackson CW, Kirby B, et al,. Cytokine gene polymorphisms in psoriasis. Br J Dermatol 2001; 144: 849-853.
15. Gonzalez S, Brautbar C, Martinez-Borra J, et al,. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol 2001; 62: 632-638.
16. Al-Heresh AM, Proctor J, Jones SM, et al,. Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology (Oxford) 2002; 41: 525-530.
17. Li B,. Tumor Necrosis Factor-Î Gene Polymorphism and Psoriasis. PhD Thesis. Shenyang: China Medical University, 2002.
18. Zhang AP,. Experimental Studies on HLA Genotyping in Patients with Psoriasis Vulgaris in Chinese Han Population. PhD Thesis. Nanjing: Nanjing Medical University, 2002.
19. Kim TG, Pyo CW, Hur SS, et al,. Polymorphisms of tumor necrosis factor (TNF) alpha and beta genes in Korean patients with psoriasis. Arch Dermatol Res 2003; 295: 8-13.
20. Baran W, Szepietowski JC, Mazur G, Baran E,. A -308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients. Acta Dermatovenerol Alp Panonica Adriat 2006; 15: 113-118.
21. Nedoszytko B, Szczerkowska-Dobosz A, Zablotna M, et al,. Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population. Br J Dermatol 2007; 157: 165-167.
22. Settin A, Hassan H, El-Baz R, Hassan T,. Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt. Acta Dermatovenerol Alp Panonica Adriat 2009; 18: 105-112.
23. Magalhaes RF, Biral AC, Pancoto JA, et al,. Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha -238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian study. Int J Dermatol 2010; 49: 1133-1140.
24. Kaluza W, Reuss E, Grossmann S, et al,. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 2000; 114: 1180-1183.
25. Sterne JA, Gavaghan D, Egger M,. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000; 53: 1119-1129.